Subscribe
Magazine
Past Issues
Surveys
Industry Statistics
About Us
Members Only
Best Places to Work
General Interest
Exploration & Development
Drilling & Production
Refining & Processing
Pipelines & Transportation
LNG
Energy Transition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
PennEnergy Stock Watch
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Dry Eye Disease
Recent news which mentions Dry Eye Disease
IVIEW Therapeutics Inc. Announces Dosing of First Patient in Phase 1/2 Clinical Trial of IVW-1001 for Dry Eye Disease
June 25, 2024
Tags
Medical
Cranbury
Science
From
PRLog
Leading Optometrist in the Brentwood neighborhood of Los Angeles, California Launches Their Redesigned Website
September 10, 2022
Tags
Eyeglasses
Scleral Contact Lenses
Health
From
PRLog
Why Aldeyra Therapeutics' Shares Are Soaring Today?
June 08, 2022
Tickers
ALDX
Tags
Movers
News
why it's moving
From
Benzinga
Aldeyra's Dry Eye Disease Candidate Disappoints In Late-Stage Study
December 21, 2021
Tickers
ALDX
Tags
Short Ideas
Movers
News
From
Benzinga
Ocular Therapeutix's Dexamethasone Ophthalmic Insert Meets Primary Goal In Dry Eye Disease Trial
December 06, 2021
Tickers
OCUL
Tags
General
Briefs
News
From
Benzinga
Aldeyra's Dry Eye Disease Trial Meets Primary Endpoint, But Did Not Reach Statistical Significance
November 02, 2021
Tickers
ALDX
Tags
ALDX
Briefs
News
From
Benzinga
FDA Approves First Nasal Spray For Dry Eye Disease From Oyster Point Pharma
October 18, 2021
Tickers
OYST
Tags
News
Briefs
General
From
Benzinga
Aerie Pharma Reports Mixed Bag On Phase 2 Dry Eye Trial
September 16, 2021
Tickers
AERI
Tags
Benzinga
FDA
Phase 2 Trial
From
Benzinga
Oyster Point Inks License Pact With Ji Xing Pharma For Dry Eye Disease Candidates In Greater China
August 06, 2021
Tickers
OYST
Tags
News
Briefs
General
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.